News | Cardiac Diagnostics | May 11, 2020

American Society for Preventive Cardiology Offers Survey to Aid Healthy Lifestyle During COVID-19

Patients encouraged to take online health assessment to see their risks of COVID-19 combined with their current cardiac risk score

American Society for Preventive Cardiology (ASPC) Offers Survey to Aid Healthy Lifestyle During COVID-19

May 11, 2020 — The American Society for Preventive Cardiology (ASPC) is collaborating with Intervent International to provide its members and their patients free access to Intervent's evidence-based, personalized, online/digital, educational resources and content. The collaboration is a patient-centered initiative to help adults play an active role in their own heart health during the COVID-19 pandemic, including heart attack/stroke prevention and recovery after a cardiac event.

As emphasized in a recent ASPC scientific statement, adults who fare poorly with COVID-19 (SARS-CoV-2) infection more commonly have risk factors for (e.g., high blood pressure, obesity and diabetes) and/or known cardiovascular disease. Moreover, while it is especially important to lead a healthy lifestyle and manage chronic medical conditions during COVID-19, traditional outpatient care services have been significantly disrupted. Many patients are delaying or deferring necessary care, including preventive care. In addition, social distancing has negatively altered physical activity and eating habits in many adults and is contributing to higher-than-usual stress levels. To make things worse, virtually all facility-based cardiac rehabilitation programs for those who have recently experienced a cardiac event (e.g., heart attack, angioplasty/stent, bypass surgery) have temporarily closed. If not promptly addressed, such changes are likely to adversely impact cardiovascular health.

In response to these challenges, as part of the ASPC/Intervent collaboration individuals can sign up for free at www.myintervent.com/aspc to:
   • Take an online health assessment and receive personalized feedback/educational content.
   • Enroll in a self-help/digital, online lifestyle management and cardiovascular disease risk reduction program.
   • Participate in monthly live group webinars.
   
The educational services are designed to help individuals make and adhere to meaningful lifestyle changes, better manage their risk factors for heart disease and stroke and, if needed, recover more successfully from a recent cardiac event. Topics include understanding heart disease, preventing and managing risk factors for heart disease, nutrition, exercise/physical activity, weight management, stress management and smoking cessation. The services are to be used as a supplement to, and not a replacement for, the advice of a physician or other healthcare provider.

"There is an urgent need during these unprecedented times to deploy innovative, evidence-based approaches to promote and preserve the health of populations at higher risk of cardiovascular disease," said Amit Khera, M.D., president of ASPC and lead author of the recent ASPC COVID-19-related scientific statement. "Given the fundamental importance of lifestyle management and other proven cardiovascular disease risk reduction strategies, we are pleased to play a role in providing ASPC's members and their patients free access to credible educational content and resources for use as a supplement to their usual medical care."  

Neil Gordon, M.D., Ph.D., co-founder and chief executive officer of Intervent, said, "The ASPC is to be complimented on the leadership role it is playing on multiple fronts to benefit society during the COVID-19 pandemic. Under the best of circumstances, it can be very challenging for many people to lead a healthy lifestyle and take other steps needed to prevent or better manage heart disease. We are especially proud to collaborate with the ASPC during this global crisis to help benefit the health and wellbeing of as many people as possible by leveraging some of our proven online/digital lifestyle management and cardiovascular disease risk reduction resources."

Related Content

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

News | Cardiac Diagnostics | July 29, 2021
July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation Ambula
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

News | Cardiac Diagnostics | July 01, 2021
July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc.
Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Detecting heart disease with OCT imaging of the eye.Getty Images

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Getty Images
 

News | Cardiac Diagnostics | March 08, 2021
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potent
Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.

Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG strip on a smartphone. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia. 

News | Cardiac Diagnostics | March 03, 2021
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management s
A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images

News | Cardiac Diagnostics | February 02, 2021
February 2, 2021 — A new study has found in the U.S.
A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

News | Cardiac Diagnostics | January 06, 2021
January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc.
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en
heart disease image
News | Cardiac Diagnostics | December 18, 2019
December 18, 2019 — In their latest report, “...